Linaclotide: a novel compound for the treatment of irritable bowel syndrome with constipation

Author： Rothstein Robin D Friedenberg Frank K

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.14, Iss.15, 2013-10, pp. : 2125-2132

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Linaclotide-a Novel Secretagogue in the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 11, 2013-10 ,pp. : 1685-1690

Bentham Science Publishers

Access to resources Recommend Favorite

Renzapride: a new drug for the treatment of constipation in the irritable bowel syndrome

By Scarpellini Emidio Tack Jan

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 11, 2008-11 ,pp. : 1663-1670

Informa Healthcare

Access to resources Recommend Favorite

Novel therapies in the treatment of irritable bowel syndrome

By Berrada Driss Lembo Tony

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 4, 2003-04 ,pp. : 635-645

Informa Healthcare

Access to resources Recommend Favorite

Lubiprostone: In Constipation-Predominant Irritable Bowel Syndrome

By Carter Natalie J. Scott Lesley J.

Drugs, Vol. 69, Iss. 9, 2009-06 ,pp. : 1229-1237

Adis International

Access to resources Recommend Favorite

The Cardiovascular Safety Profile of Renzapride, a Novel Treatment for Irritable Bowel Syndrome

By Meyers NL Hickling RI

The Journal of International Medical Research, Vol. 35, Iss. 6, 2007-11 ,pp. : 848-866

Field House Publishing

Access to resources Recommend Favorite